Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Oct 17, 2022 5:23pm
127 Views
Post# 35030096

RE:RE:RE:Microbix T.MBX could test 52 week highs....

RE:RE:RE:Microbix T.MBX could test 52 week highs....Good question. Personally I think that term was being used by Cameron in relation to significantly higher QAPs sales. It's difficult to say because of the timing of the first announcement which was later than anyone expected, including them. However, they were selling to this customer prior to the announcement of the formal five year agreement. So it depends on how much they were selling to this customer prior to the formal announcement, are they doing the same with other customers who's formal agreements are yet to be announced, and what your expectations are for a transformative QAPs revenue number. I don't think it will meet my expectation of transformative but I think it will be a great and record number with much much more to come. Hopefully they will surprise me and I do think that possibility exists although not probable. 
<< Previous
Bullboard Posts
Next >>